BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/3/2021 7:34:23 AM | Browse: 1077 | Download: 2589
 |
Received |
|
2021-04-26 07:33 |
|
Peer-Review Started |
|
2021-04-26 07:36 |
|
First Decision by Editorial Office Director |
|
2021-06-13 04:55 |
|
Return for Revision |
|
2021-06-13 04:55 |
|
Revised |
|
2021-06-23 07:57 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-09-02 02:54 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-09-02 09:00 |
|
Articles in Press |
|
2021-09-02 09:00 |
|
Edit the Manuscript by Language Editor |
|
2021-11-23 08:22 |
|
Typeset the Manuscript |
|
2021-12-01 01:56 |
|
Publish the Manuscript Online |
|
2021-12-03 07:34 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Multimodality management of gallbladder cancer can lead to better outcome: Experience from a tertiary care oncology centre in North India
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Shaifali Goel, Abhishek Aggarwal, Assif Iqbal, Vineet Talwar, Swarupa Mitra and Shivendra Singh |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Shivendra Singh, MCh, MS, Chief Physician, Consultant Physician-Scientist, Senior Research Fellow, Department of GI and HPB Oncosurgery, Rajiv Gandhi Cancer Institute and Research Center, Dinbandhu Choturam Marg, Sector 5, Delhi 110085, Delhi, India. shiven_24@yahoo.co.in |
| Key Words |
Gall bladder cancer; Multimodality; Surgical resection; Adjuvant; Chemotherapy; Chemoradiotherapy |
| Core Tip |
Gallbladder cancer (GBC) is an aggressive malignancy with only 10% cases amenable to resection at presentation and dismal overall 5-year survival of 5%-13% after curative surgery. Recently several experts have recommended that multimodality treatment, including neoadjuvant and adjuvant therapies can improve survival. In this study, we share our experience with multimodality approach in GBC. Five years overall survival was approaching 50% and therefore we suggest that such approach can improve survival in this aggressive malignancy. |
| Publish Date |
2021-12-03 07:34 |
| Citation |
Goel S, Aggarwal A, Iqbal A, Talwar V, Mitra S, Singh S. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India. World J Gastroenterol 2021; 27(45): 7813-7830
|
| URL |
https://www.wjgnet.com/2219-2840/full/v27/i45/7813.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i45.7813 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
